Medical Condition News

RSS

Expert review of respiratory medicine on pulmonary hypertension

Pulmonary hypertension (PH) is a rare, often incurable lung disorder that affects individuals of all ages, races and ethnic backgrounds. In the recent 4th World Conference on Pulmonary Hypertension held by the WHO, PH was classified into five groups based on its causes, highlighting both the magnitude of conditions associated with PH and how little we know of the etiology in many cases.

23 May 2011

Substantial portion of patients with headaches improve without treatment

Headache is a very common complaint, with over 90% of all persons experiencing a headache at some time in their lives. Headaches commonly are tension-type (TTH) or migraine. They have high socioeconomic impact and can disturb most daily activities. Treatments range from pharmacologic to behavioral interventions.

23 May 2011

Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting

Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels).

23 May 2011

Elixir DESyne Drug Eluting Coronary Stent System granted CE Mark approval

Elixir Medical Corporation, a developer of product platforms combining state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE Mark for its DESyne Drug Eluting Coronary Stent System for the treatment of coronary artery disease.

23 May 2011

Lifestyle modifications help control blood pressure levels: More evidence

Evidence continues to build that lifestyle modifications help control blood pressure (BP) levels. Data evaluating the consumption of coffee and alcohol and the impact of low fitness levels will be presented at the American Society of Hypertension, Inc.'s 26th Annual Scientific Meeting and Exposition (ASH 2011) and will be featured in the May 22 ASH press briefing.

23 May 2011

OptiNose wins 200,000 NOK award for novel bi-directional nasal drug delivery technology

OptiNose Inc. announced that the Company has recently won the Oslo regional finals of the DnB NOR Innovation Award for its novel, bi-directional nasal drug delivery technology.

23 May 2011

Sangamo announces presentations of ZFP Therapeutics data at ASGCT 2011

Sangamo BioSciences, Inc. announced today that data from clinical, preclinical and research-stage programs focused on the development of zinc finger DNA-binding protein Therapeutics were described in twenty presentations given by Sangamo scientists and collaborators at the 14th Annual Meeting of the American Society of Gene and Cell Therapy.

23 May 2011

Nano-complex pre-meal dietary supplement can reduce fat and sugar absorption in the body

A little bitter with a little sweet, in the form of a nano-complex dietary supplement taken before meals, can result in a substantial reduction of fat and sugar absorption in the body, Hebrew University of Jerusalem and Harvard University researchers have found.

23 May 2011

Mylan introduces Divalproex Sodium Capsules for treatment of seizures

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Divalproex Sodium Capsules USP, 125 mg, the generic version of Abbott's Depakote® Sprinkle Capsules, a treatment for certain types of seizures.

23 May 2011

Micromet's blinatumomab data to be presented at two upcoming medical meetings

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab will be reported at two upcoming medical meetings.

23 May 2011

Millennium Laboratories founder to be honored as 2011 Ernst & Young Entrepreneur for pain care

Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today that James Slattery, CEO and founder, is a regional finalist for the Ernst & Young Entrepreneur of the Year 2011 San Diego region.

23 May 2011

New technique can detect minute traces of tumoral DNA in biological fluids

It will perhaps be possible, in the near future, to detect cancer by a simple blood or urine test. In fact, biologists from CNRS, Inserm, Paris Descartes and Strasbourg universities have developed a technique capable of detecting minute traces of tumoral DNA present in the biological fluids of patients suffering from cancer.

23 May 2011

Cognitive behavioural treatment can serve as effective alternative to GA for patients with dental phobia

A study published in the current issue of Psychotherapy and Psychosomatics examines a relatively frequent problem. Individuals who fear the dentist should often recur to some kinds of general anaesthesia to have their dental work done. But alternatives are now available.

23 May 2011

Pieris' PRS-080 preclinical data in anemia presented at International BioIron Society Meeting

Pieris AG announced today preclinical in vitro and in vivo data for its PRS-080 Anticalin antagonist program targeting hepcidin, a small peptide which plays a pivotal role in the regulation of iron levels in the blood.

23 May 2011

Cognitive-behavioral therapy helps treat hypochondriasis

In a study published in the current issue of Psychotherapy and Psychosomatics the mechanisms underlying improvement in hypochondriasis are examined.

23 May 2011

New RHUCIN study data in acute HAE attacks presented at 7th C1 Inhibitor Deficiency Workshop

Santarus, Inc., a specialty biopharmaceutical company, today announced that new data from open-label studies evaluating the efficacy and safety of the investigational drug RHUCIN for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema were presented at the 7th C1 Inhibitor Deficiency Workshop on May 20 - 22, 2011 in Budapest, Hungary.

23 May 2011

Cognitive behavioral group therapy may help prevent new episodes of bipolar disorder

In the current issue of Psychotherapy and Psychosomatics a randomized controlled trial indicates that group therapy may affect the course of bipolar disorder. This study evaluated the effectiveness of adjunctive cognitive behavioral group therapy to prevent recurrence of episodes in 50 euthymic patients with bipolar disorder types I and II followed up for at least 12 months in an outpatient service and whose disease was in remission.

23 May 2011

Novel compound could become an effective alternative to common narcotic analgesics

Scientists from the Florida campus of The Scripps Research Institute have for the first time accomplished a laboratory synthesis of a rare natural product isolated from the bark of a plant widely employed in traditional medicine.

23 May 2011

Phytoceuticals to present promising clinical data on 1 PRIMARY WOUND DRESSING at EWMA 2011

Phytoceuticals Ltd. will present promising clinical and scientific data on 1 PRIMARY WOUND DRESSING at the 2011 EWMA Conference on May 26, the largest European wound management conference.

23 May 2011

New data from ProSavin Phase I/II trial in Parkinson's presented at ASGCT annual meeting

Oxford BioMedica, a leading gene therapy company, announces that new data from the on-going Phase I/II trial of ProSavin for the treatment of Parkinson's disease were presented at the American Society of Gene & Cell Therapy 14th Annual Meeting held in Seattle, USA by Professor Stephane Palfi, Principal Investigator at the Henri Mondor Hospital in Paris, on Saturday 21 May 2011.

23 May 2011

Medical Condition News

Expert review of respiratory medicine on pulmonary hypertension

Substantial portion of patients with headaches improve without treatment

Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting

Elixir DESyne Drug Eluting Coronary Stent System granted CE Mark approval

Lifestyle modifications help control blood pressure levels: More evidence

OptiNose wins 200,000 NOK award for novel bi-directional nasal drug delivery technology

Sangamo announces presentations of ZFP Therapeutics data at ASGCT 2011

Nano-complex pre-meal dietary supplement can reduce fat and sugar absorption in the body

Mylan introduces Divalproex Sodium Capsules for treatment of seizures

Micromet's blinatumomab data to be presented at two upcoming medical meetings

Millennium Laboratories founder to be honored as 2011 Ernst & Young Entrepreneur for pain care

New technique can detect minute traces of tumoral DNA in biological fluids

Cognitive behavioural treatment can serve as effective alternative to GA for patients with dental phobia

Pieris' PRS-080 preclinical data in anemia presented at International BioIron Society Meeting

Cognitive-behavioral therapy helps treat hypochondriasis

New RHUCIN study data in acute HAE attacks presented at 7th C1 Inhibitor Deficiency Workshop

Cognitive behavioral group therapy may help prevent new episodes of bipolar disorder

Novel compound could become an effective alternative to common narcotic analgesics

Phytoceuticals to present promising clinical data on 1 PRIMARY WOUND DRESSING at EWMA 2011

New data from ProSavin Phase I/II trial in Parkinson's presented at ASGCT annual meeting

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News